5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study

Documenti analoghi

• Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent
  di: Jameson, M B, et al.
  Pubblicazione: (2003)
• Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.
  di: Lash, C. J., et al.
  Pubblicazione: (1998)
• Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
  di: Ching, L-M, et al.
  Pubblicazione: (2002)
• Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
  di: Tijono, S M, et al.
  Pubblicazione: (2013)
• The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice
  di: Zhao, L, et al.
  Pubblicazione: (2002)